Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "ASC2ESCALATE: A US Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Pts With CML-CP Previously Treated With 1 Prior TKI"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jorge Cortés
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jorge Cortés
83 views
June 14, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology